tiprankstipranks
Trending News
More News >
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Financial Statements

Compare
477 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently $3.17M. The company's EPS TTM is $-0.72; its P/E ratio is ―; Artelo Biosciences is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 21Sep 20Sep 19Sep 18
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -10.29M$ -7.44M$ -4.69M$ -3.21M$ -2.34M
EBITDA$ -10.29M$ -7.44M$ -4.71M$ -4.22M$ -2.34M
Net Income$ -9.87M$ -7.44M$ -4.65M$ -2.17M$ -2.34M
Balance Sheet
Cash & Short-Term Investments$ 17.53M$ 10.06M$ 2.14M$ 4.42M$ 337.42K
Total Assets$ 20.42M$ 12.63M$ 4.38M$ 6.48M$ 397.00K
Total Debt$ 63.00K$ 95.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -6.83M$ -6.53M$ -2.14M$ -4.42M$ -337.42K
Total Liabilities$ 1.02M$ 593.00K$ 502.18K$ 1.02M$ 531.97K
Stockholders' Equity$ 19.40M$ 12.04M$ 3.87M$ 5.46M$ -134.97K
Cash Flow
Free Cash Flow$ -8.01M$ -6.14M$ -4.35M$ -4.29M$ -1.61M
Operating Cash Flow$ -8.01M$ -6.14M$ -4.35M$ -2.79M$ -1.61M
Investing Cash Flow$ 2.96M$ -3.44M$ 0.00$ -1.50M$ -845.00
Financing Cash Flow$ 0.00$ 14.11M$ 1.98M$ 8.38M$ 1.39M
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis